Medication Related Osteonecrosis of the Jaws

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Aurum Journal of Health Sciences
Volume:2 Issue:1
Medication Related Osteonecrosis of the Jaws

Medication Related Osteonecrosis of the Jaws

Authors : Semih ÖZBAYRAK, Özlem OKUMUŞ

Pages : 41-56

View : 54 | Download : 11

Publication Date : 2020-01-31

Article Type : Review Paper

Abstract :Medication-related osteonecrosis of the jaw insert ignore into journalissuearticles values(MRONJ); is a severe adverse drug reaction, including of bone destruction in the jaws. Osteonecrosis of the jaws can be caused by two pharmacological agents: antiresorptive insert ignore into journalissuearticles values(including bisphosphonates insert ignore into journalissuearticles values(BPs); and receptor activator of nuclear factor kappa-B ligand [RANK-L] inhibitors); and antiangiogenic. Among the drugs associated with the development of MRONJ, BPs are the most widely used for a wide variety of clinical indications. Bisphosphonates are used in bone metabolism-related diseases such as Paget’s disease, fibrous dysplasia, osteogenesis imperfecta, but mainly in lung, prostate, breast carcinomas, multiple myeloma and osteoporosis. The effect of the drug depends on the dose and duration of administration. Epidemiological studies showed that long-term use of these drugs may increase the risk of MRONJ development. The purpose of this review is to define the current information about MRONJ, the management strategies and preventive measures.
Keywords : biphosphonate, drug therapy, osteochemonecrosis, osteonecrosis of the jaw

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.